SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-054058
Filing Date
2021-08-31
Accepted
2021-08-31 16:04:57
Documents
2
Period of Report
2021-08-27

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4019
2 POA DOCUMENT poa.txt EX-24.4_1006458 3165
  Complete submission text file 0001209191-21-054058.txt   8519
Mailing Address 1800 KRAFT DRIVE, SUITE 216 BLACKSBURG VA 24060
Business Address 1800 KRAFT DRIVE, SUITE 216 BLACKSBURG VA 24060 540-818-2844
Landos Biopharma, Inc. (Issuer) CIK: 0001785345 (see all company filings)

IRS No.: 815085535 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 100 HIGH STREET 28TH FLOOR BOSTON MA 02110
Business Address
Callori Fred (Reporting) CIK: 0001843393 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39971 | Film No.: 211227041